AUSTIN, TX (February 24, 2016) – The results and methodologies from the Alpha BRAIN clinical trial were accepted and published by the Journal of Human Psychopharmacology: Clinical and Experimental.
The randomized, double blind, placebo-controlled study conducted by the Boston Center for Memory assigned 63 participants to take either one serving of Alpha Brain or a placebo for 45 days.
Subjects were evaluated before and after the supplementation period using validated neuropsychological assessments. The demographics of the subject group included mostly healthy 18 to 35-year-old males and females with above average education and IQ score.
Onnit Alpha Brain
The results indicate that supplementation with Alpha BRAIN can improve memory and executive function in healthy adults.
The results indicate that supplementation with Alpha BRAIN can improve memory and executive function in healthy adults.
There were no noticeable differences in cognitive performance nor demographics between the two groups at the beginning of the study.
The results indicate that supplementation with Alpha BRAIN can improve memory and executive function in healthy adults. Although both groups improved over time, the performance on two assessments in the Alpha BRAIN group exceeded the placebo group to a clear statistically significant margin.
Specifically, those who took Alpha BRAIN improved their ability to recall a list of words recited to them 20 minutes earlier, thereby improving their delayed verbal recall.
The Alpha BRAIN group also significantly outperformed the placebo group in a test that asks participants to draw a line connecting alternating numbers and letters in sequence as quickly as possible.
Faster completion times reflect better executive function or a set of higher cognitive processes that rely upon attention, memory, inhibition and mental flexibility.
The CEO of Onnit Labs, Aubrey Marcus, commented, “To see our Alpha BRAIN trial published in a major journal is a significant milestone. To know that the results and methodologies of the study were validated through the rigorous peer review process supports a scientific opinion that we are offering the absolute best nootropic supplement utilizing earth grown nutrients in existence. Onnit will continue its mission to provide primary, peer-reviewed research on all of its flagship formulas.”
No significant side effects were reported in either group and study compliance was high, indicating overall good tolerability with daily Alpha BRAIN use. Furthermore, there were no differences in sleep quality between the two groups.